ID   WERI-Rb-24
AC   CVCL_S609
SY   WERI-Rb24; WERI-24; W-24; W24; Wills Eye Research Institute-Retinoblastoma-24
DR   cancercelllines; CVCL_S609
DR   Cosmic; 808516
DR   Wikidata; Q54993777
RX   PubMed=2391623;
RX   PubMed=2594029;
CC   Doubling time: 1.6 days (PubMed=2391623).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg358Ter (c.1072C>T); ClinVar=VCV000013076; Zygosity=Unspecified (PubMed=2594029).
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
RX   PubMed=2391623; DOI=10.3928/0191-3913-19900701-11;
RA   Sery T.W., Lee E.Y.-H.P., Lee W.-H., Bookstein R., Wong V.,
RA   Shields J.A., Augsburger J.J., Donoso L.A.;
RT   "Characteristics of two new retinoblastoma cell lines: WERI-Rb24 and
RT   WERI-Rb27.";
RL   J. Pediatr. Ophthalmol. Strabismus 27:212-217(1990).
//
RX   PubMed=2594029; DOI=10.1056/NEJM198912213212501;
RA   Yandell D.W., Campbell T.A., Dayton S.H., Petersen R., Walton D.,
RA   Little J.B., McConkie-Rosell A., Buckley E.G., Dryja T.P.;
RT   "Oncogenic point mutations in the human retinoblastoma gene: their
RT   application to genetic counseling.";
RL   N. Engl. J. Med. 321:1689-1695(1989).
//